Publications
5674 Results
- Journal / Conference
- Journal of Clinical Oncology 26(15S):433s, #8039
- Year
- 2008
- Research Committee(s)
- Lung
- Study Number(s)
- S0435
Sorafenib in patients with platinum (plat) treated extensive stage small cell lung cancer (E-SCLC): a SWOG (S0435) phase II trial
- Journal / Conference
- Journal of Clinical Oncology 26(4):527-534
- Year
- 2008
- Research Committee(s)
- Melanoma
- Study Number(s)
- SWOG-8118, SWOG-8240, SWOG-8324, SWOG-8562, SWOG-8569, SWOG-8723, SWOG-8754, SWOG-8804, SWOG-8913, SWOG-8921, SWOG-9116, SWOG-9223, SWOG-9228, SWOG-9348, SWOG-9350, SWOG-9505, S9622, S9804
Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials. [PMID18235113]
- Journal / Conference
- The Prostate 68:281-286
- Year
- 2008
- Research Committee(s)
- Cancer Control
- PMID
- PMID18163420
- Study Number(s)
- SWOG-9217
Finasteride, prostate cancer, and weight gain: evidence for genetic or environmental factors that affect cancer outcomes during finasteride treatment
- Journal / Conference
- Urology 71(5):967-970
- Year
- 2008
- Research Committee(s)
- Cancer Control
- PMID
- PMID18267333
- PMC
- PMC2387066
- Study Number(s)
- SWOG-9217
Extraction of DNA from serum for high-throughput genotyping: findings from pilot studies within the Prostate Cancer Prevention Trial
- Journal / Conference
- Journal of Clinical Oncology 26(20)3351-3357
- Year
- 2008
- Research Committee(s)
- Lung
- Study Number(s)
- S0342
Increased EGFR gene copy number detected by FISH predicts outcome in non-small cell lung cancer patients treated with cetuximab and chemotherapy [PMID18612151;PMC3368372]
- Journal / Conference
- Journal of Urology 180(2):544-547
- Year
- 2008
- Research Committee(s)
- Cancer Control
- PMID
- PMID18550097
- PMC
- https://www.ncbi.nlm.nih.gov/pubmed/18550097
- Study Number(s)
- SWOG-9217
The performance of prostate specific antigen for predicting prostate cancer is maintained after a prior negative prostate biopsy
- Journal / Conference
- Journal of Clinical Oncology 26(4):626-632
- Year
- 2008
- Research Committee(s)
- Sarcoma
- Study Number(s)
- S0033
Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033 [PMID18235122]
- Journal / Conference
- American Journal of Epidemiology 168(12):1416-1424
- Year
- 2008
- Research Committee(s)
- Cancer Control
- Study Number(s)
- SWOG-9217
Serum steroid and sex hormone binding globulin concentrations and the risk of incident benign prostatic hyperplasia (BPH): Results from the Prostate Cancer Prevention Trial. PMC2387066; PMID: 18267333.
- Journal / Conference
- Prostate 68(13):1477-1486
- Year
- 2008
- Research Committee(s)
- Cancer Control
- PMID
- PMID18618736
- PMC
- PMC2564287
- Study Number(s)
- SWOG-9217
Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and risk of benign prostate hyperplasia in the Prostate Cancer Prevention Trial
- Journal / Conference
- American Journal of Epidemiology 167(3):362-368
- Year
- 2008
- Research Committee(s)
- Cancer Control
- PMID
- PMID179821157
- PMC
- PMC2939738
- Study Number(s)
- SWOG-9217